Sirolimus: a ten-year perspective
- 1 January 2004
- journal article
- review article
- Published by Elsevier in Transplantation Proceedings
- Vol. 36 (1) , 71-75
- https://doi.org/10.1016/j.transproceed.2003.11.039
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicityClinical Transplantation, 2000
- An immunoassay for the measurement of sirolimusClinical Therapeutics, 2000
- The quantification of sirolimus by high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in renal transplant recipientsClinical Therapeutics, 2000
- IMMUNOSUPPRESSIVE EFFECTS AND SAFETY OF A SIROLIMUS/CYCLOSPORINE COMBINATION REGIMEN FOR RENAL TRANSPLANTATION1Transplantation, 1998
- Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progressionClinical Biochemistry, 1998
- Determination of Rapamycin in Whole Blood by HPLCTherapeutic Drug Monitoring, 1997
- The side effect profile of sirolimus: A phase I study in quiescent cyclosporine-prednisone-treated renal transplant patientsKidney International, 1996
- RAPAMYCIN FOR IMMUNOSUPPRESSION IN ORGAN ALLOGRAFTINGThe Lancet, 1989
- Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.The Journal of Antibiotics, 1975
- Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.The Journal of Antibiotics, 1975